Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

New neurological and immunological therapies basis of Neurocrine Biosciences-Caliper collaboration

Jan. 19, 1999

LeukoSite, Warner-Lambert collaborate on integrin antagonist research

Jan. 19, 1999

Targeted Genetics, Sangamo combine two novel technologies for drug discovery

Jan. 19, 1999

Palatin and Nihon Medi-Physics intend to develop radiopharmaceutical products

Jan. 18, 1999

Tenth HuMAb-Mouse licensing agreement for Medarex: Immunex granted broad rights

Jan. 18, 1999

Milestone reached by Cadus in drug discovery collaboration with SmithKline Beecham

Jan. 18, 1999

Rigel and Janssen enter drug discovery collaboration

Jan. 15, 1999

Isis and Abbott establish antisense target validation partnership

Jan. 15, 1999

VP22 increases the efficacy of suicide gene therapy in vivo

Jan. 15, 1999

Telik and Cor Therapeutics enter drug screening and licensing agreement

Jan. 14, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...